| Partnership

RWTH Aachen
Helmoltz - Institute for Biomedical Technologies
Address
Pauwelsstrasse, 20
D-52074 Aachen (Germany)
Ph. +49 (0)241-80-87111
Fax +49 (0)241-80-82442 www.hia.rwth-aachen.de/ |
Business activities
Since its foundation in 1971, the Helmoltz-Institute,
which is affiliated with the Aachen University of Technology (Rheinisch-Westfälische
Technische Hochschule, RWTH) operates as a bridge between the engineering
and natural sciences and the medical disciplines. For this reason,
the Institute was named after Hermann von Helmoltz (1821-1894),
a scientific pioneer who introduced the exact sciences to physiology
and medicine. The Helmoltz-Institute is an institute of the Medical
Faculty and actively co-operates with the faculties of the RWTH.
A number of joint research projects and jointly advised doctoral
dissertations in medicine, engineering and the natural sciences
have resulted from this co-operation.
The Helmoltz-Institute’s primary research activities
focus upon the medical field and, in particular, aims to solve clinically
oriented problems requiring an interdisciplinary approach. The Institute
also provides technical assistance during the development and clinical
testing of such projects. In addition, co-operation with industrial
partners provides the Institute with the opportunity to address
research and development as well as testing, integration and validation
of new technologies and methods for clinical usage. Research within
the Helmoltz-Institute is performed within four complementary work
groups with the following topics: Biomechanics (Cardiovascular Engineering),
Cryobiology, Biophysical Measurement Techniques and Surgical Therapy
Technology.
The traditional research areas of the Cardiovascular
Engineering Group are in the cardiovascular area. Basic researches
as well as applied projects in the fields of blood pumps and heart
valves are main foci.
Several of the Institute developments have already been successfully
transferred into clinical application, while others are in clinical
testing or shortly before. New research and development projects
have been initiated as well under European as industrial grants.
Besides the above mentioned, main research areas further activities
are ongoing in the fields of flow- and material-induced blood damage
as well as bio and hemocompatibility of Biomaterials. |